Piramal Pharma Limited (BOM:543635)

India flag India · Delayed Price · Currency is INR
189.70
-2.05 (-1.07%)
At close: Aug 8, 2025
-1.07%
Market Cap252.38B
Revenue (ttm)91.34B
Net Income (ttm)980.70M
Shares Outn/a
EPS (ttm)0.73
PE Ratio257.35
Forward PE91.57
Dividend0.14 (0.07%)
Ex-Dividend DateJul 16, 2025
Volume166,768
Average Volume280,253
Open191.85
Previous Close191.75
Day's Range188.90 - 196.05
52-Week Range179.25 - 307.85
Betan/a
RSI38.15
Earnings DateJul 28, 2025

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, inje... [Read more]

Industry Pharmaceutical Preparations
Founded 2020
Employees 5,476
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543635
Full Company Profile

Financial Performance

In 2024, Piramal Pharma's revenue was 91.51 billion, an increase of 11.99% compared to the previous year's 81.71 billion. Earnings were 911.30 million, an increase of 411.39%.

Financial Statements

News

There is no news available yet.